Objectives: To report an unusual cause of intrathecal drug delivery failure in baclofen pump device. Study design:A case report of an SCI patient treated with intrathecal baclofen, presenting a drug ...

September 14, 2012 — The US Food and Drug Administration (FDA) has approved a new catheter (Ascenda, Medtronic Inc) for use in the delivery of intrathecal baclofen (ITB) therapy. According to the ...

A novel indwelling subcutaneous intrathecal catheter circumvented the complex spine anatomy of patients with spinal muscular atrophy (SMA), a challenge when giving nusinersen via intrathecal injection ...

July 24, 2006 — The US Food and Drug Administration (FDA) and Medtronic, Inc, have warned healthcare professionals via letter regarding the worldwide voluntary recall of nonimplanted intrathecal ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has classified its safety alert about the proper connection of sutureless ...

A study presented at the 2011 annual meeting of the Society of Obstetric Anesthesia and Perinatology found that women undergoing C-sections may require a smaller dose of anesthesia when administered ...

CHICAGO (Reuters) - Medtronic Inc said on Friday that U.S. health regulators classified its safety alert about the proper connection of sutureless catheters used with implantable drug infusion systems ...

Intrathecal drug administration via lumbar puncture and a spinal access port device led to serious complications in a patient receiving experimental therapy for Niemann-Pick type C. In a case report ...

LOWELL, Mass., July 31, 2024 /PRNewswire/ -- Alcyone Therapeutics Inc. (Alcyone), a clinical-stage biotechnology company pioneering next-generation precision genetic therapies and precision delivery ...

The Intrathecal Drug Pain Pump Market has garnered significant attention due to its pivotal role in providing targeted pain management solutions. These devices, designed for intrathecal drug delivery, ...

Biogen has partnered with Alcyone Therapeutics to improve the delivery of its spinal muscular atrophy drug Spinraza, handing over $10 million upfront for a global license to an implantable device.